HIGHLIGHTS
- who: Posted Date November and collaborators from the Beijing Technology and Business University have published the paper: Brevilaterin B from Brevibacillus laterosporus has selective antitumor activity and induces apoptosis in epidermal cancer, in the Journal: (JOURNAL)
- what: The aim of this work was to evaluate the activity exerted by the AMP Brevilaterin B against various human cancer cell lines and the ability of Brevilaterin B to induce apoptosis in epidermal cancer cell lines in_vitro.
- how: The results showed that 2 µg/mL of Brevilaterin B could induce LDH release from the cancer cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.